Patients with leptomeningeal metastasis (LM) have historically had few treatment options. Now, researchers from The University of Texas MD Anderson Cancer Center have found a combination of targeted ...

Now, the person making the call is somebody somewhere who works for (the insurance company). It’s not my physician, who’s an expert.” | Opinion ...

Significantly more patients had no chemotherapy-induced thrombocytopenia-induced modification of chemo dose with romiplostim vs placebo.

The very first patient would receive the first clinical doses of HMBD-001, the first cancer treatment from Hummingbird Bioscience. Piers Ingram, the cofounder and CEO of the company, was nervous, but ...

AIM ImmunoTech (AIM) stock jumped 97% after Japan's Patent Office approved its Ampligen cancer treatment patent covering multiple cancer types through 2039.

Resistance to therapy and tumor heterogeneity remain the fundamental drivers of treatment failure in oncology. While single-agent therapies have provided ...

A £1 million research project led by the University of Sheffield is developing a new generation of “smart” drug delivery ...

One of oncology's biggest challenges is that the same treatment can work well for some patients but fail completely in others.